Gerresheimer (OTCMKTS:GRRMF) Trading 6% Higher – Time to Buy?

Gerresheimer AG (OTCMKTS:GRRMF)’s share price shot up 6% on Wednesday . The company traded as high as $56.75 and last traded at $56.75. 100 shares traded hands during mid-day trading, a decline of 84% from the average session volume of 633 shares. The stock had previously closed at $53.55.

Analyst Upgrades and Downgrades

Several research analysts have commented on GRRMF shares. Sanford C. Bernstein downgraded shares of Gerresheimer to an “underperform” rating in a report on Tuesday, June 3rd. Barclays restated an “overweight” rating on shares of Gerresheimer in a research report on Tuesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft cut shares of Gerresheimer from a “buy” rating to a “hold” rating in a research report on Tuesday, June 3rd.

Gerresheimer Stock Performance

The firm’s 50-day moving average is $59.69 and its 200-day moving average is $68.81.

Gerresheimer Company Profile

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.